Skip to main content
Premium Trial:

Request an Annual Quote

NINDS to Fund Research Core Facilities, Including Genomics, With Up to $2.5M Each

NEW YORK, March 21 (GenomeWeb News) - The National Institute of Neurological Disorders and Stroke plans to fund a number of centralized resources and facilities at research institutions, including those offering genomic technologies, to support neuroscience research, the institute said on Friday.

 

Under the program, called "NINDS Institutional Center Core Grants to Support Neuroscience Research," NINDS will support core facilities shared by investigators with existing NINDS-funded research projects. Cores can receive up to $500,000 per year in direct costs for up to five years. NINDS did not specify the number of awards or total amount of funding it plans to disburse.

 

Eligible research cores include those providing assay development, DNA sequencing, mass spectrometry, microarrays, proteomics, and protein crystallography.

 

To view the complete program announcement, click here.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.